Rifaximin, a minimally absorbed broad-spectrum oral antibiotic, is used to target gut dysbiosis in patients with irritable bowel syndrome (IBS).However, conflicting trial data and methodological heterogeneity necessitate an updated, rigorous synthesis of its efficacy and safety profile.We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) comparing rifaximin with placebo in adult patients with IBS, adhering to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 guidelines.The primary outcome was global symptom relief at the end of the treatment.Data were pooled using inverse-variance random-effects models with Hartung-Knapp-Sidik-Jonkman (HKSJ) adjustment.Evidence robustness was evaluated using prediction intervals (PI), Trial Sequential Analysis (TSA), trim-and-fill algorithms for publication bias, and the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology.Nine RCTs (yielding 10 randomized comparisons due to one trial's a priori stratification by small intestinal bacterial overgrowth status) were included in this review.For the primary outcome (eight comparisons, N=2,056), rifaximin significantly improved global symptom relief compared to placebo (RR 1.54, 95% CI 1.13 to 2.11; p=0.014), corresponding to a number needed to treat for benefit (NNTB) of 6.However, statistical heterogeneity was substantial (I 2 =59.5%), and the 95% PI crossed the line of no effect (0.89-2.67).The primary effect lost statistical significance upon the exclusion of high-risk-of-bias trials (RR 1.47, 95% CI 0.95-2.27)and after adjusting for publication bias using the trim-and-fill method (RR 1.37, 95% CI 0.93-2.01).The TSA indicated that the accrued information size remained inconclusive for a conservative 15% relative benefit.Rifaximin demonstrated no statistically detectable difference in adverse events compared to placebo, though this is accompanied by considerable uncertainty (Peto OR 0.89 (95% CI 0.65-1.22)).Rifaximin demonstrates a modest overall benefit for global IBS symptoms and an excellent safety profile; however, the certainty of evidence is very low.The apparent efficacy is highly fragile, driven largely by industry-funded trials, undermined by publication bias, and characterized by wide prediction intervals.Biomarker-guided stratification, such as testing for small intestinal bacterial overgrowth (SIBO), may be required to optimize patient selection in future independent trials.
The incidence of suicide, self-harm, and mental crises among teenagers is rising, presenting significant global public health issues. Conventional clinical risk evaluations have inadequate predictive accuracy, often overlooking high-risk adolescents. Machine learning models employing electronic health records provide an innovative method for predicting mental health crises through the integration of intricate clinical data patterns. Hence, this review aims to comprehensively examine and synthesize information about machine learning models created using electronic health record data for predicting suicide attempts, self-harm, or mental hospitalization in teenagers. Adhering to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) principles, we executed an exhaustive search across six databases (2000-2025) for peer-reviewed research utilizing machine learning algorithms on electronic health record data to predict adolescent mental health crises. The inclusion criteria emphasized structured or unstructured electronic health record inputs, teenage cohorts (ages 10-20), and performance indicators like area under the curve (AUC), sensitivity, or specificity. The Prediction Model Risk of Bias Assessment Tool (PROBAST) was utilized to evaluate the risk of bias. Our search yielded five studies (2019-2024) that satisfied the inclusion criteria. All studies were retrospective cohorts conducted in high-income nations. Structured electronic health record data (e.g., diagnoses, prescriptions) were frequently utilized; two studies included natural language processing. Machine learning models demonstrated moderate to high discrimination (AUC 0.68-0.88), exhibiting optimal performance in short-term suicide prediction with hybrid data inputs. All investigations, however, exhibited a significant risk of bias in the analysis domain owing to insufficient external validation and absent calibration data. The positive predictive values consistently remained modest across all models. Overall, machine learning models demonstrate potential for enhancing adolescent suicide risk classification utilizing electronic health record data, surpassing numerous traditional instruments. Nonetheless, issues of generalizability, ethical constraints, and implementation obstacles remain. Thorough validation, calibration, and equity assessments are necessary prior to incorporation into clinical practice.
adolescent mental healthsuicide risk predictionself-harmelectronic health records
Neuro-developmental delay (NDD) is when a child's reflexes and nervous system are underdeveloped or immature at a given stage of child development. Neurodevelopmental delays account for delayed skill development surrounding speech, social, emotional, behavioral, motor, and cognitive delays. NDD might affect the child's psychological and physical well-being, resulting in chronic disease and disabilities throughout adulthood. This review sought to investigate the implication of early diagnosis and intervention of NDD in children. In this regard, this research opted for a systematic meta-analysis that used keywords and Boolean operators to search through main databases, including the Web of Science, JStor, PsychINFO, Science Direct, Cochrane, Scopus, and ASSIA. The result identified that telehealth interventions improved the management of NDD in children. Also, the Early Start Denver Model (ESDM) model was determined to improve the quality of life for NDD children. Another model was LEAP (Learning Experience and Alternative Program for Preschoolers and Their Parents) and Leap (Learning, engaging, and Playing), which improved behavioral, education, and social interventions in NDD children. The study identified that technology could revolutionize NDD interventions in children, possibly improving the quality of life. The parent-children relationship was shown to enhance the management of this condition; thus, it is recommended as one of the best ways to intervene in the management of NDD. Most importantly, the integration of machine learning algorithms and technology can create models; while this may not be significant in the treatment of childhood NDD but instead might be ideal in improving the quality of life for NDD children. Moreover, their social and communication skills along with academic achievements will improve. The study proposes further research in order to understand the different types of NDDs and their intervention strategies to help the researchers identify the most accurate models to improve the conditions and support the parents and guardians in the management.